Nonsteroidal Anti-inflammatory Drugs and 5-HT 3 Serotonin Receptor Antagonists as Innovative Antipsychotic Augmentation Treatments for Schizophrenia

Chittaranjan Andrade
  • The Journal of Clinical Psychiatry, July 2014, Physicians Postgraduate Press, Inc
  • DOI: 10.4088/jcp.14f09292
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Chittaranjan Andrade